[go: up one dir, main page]

FI922905A0 - Framstaellning och anvaendning av imidazolfoereningar. - Google Patents

Framstaellning och anvaendning av imidazolfoereningar.

Info

Publication number
FI922905A0
FI922905A0 FI922905A FI922905A FI922905A0 FI 922905 A0 FI922905 A0 FI 922905A0 FI 922905 A FI922905 A FI 922905A FI 922905 A FI922905 A FI 922905A FI 922905 A0 FI922905 A0 FI 922905A0
Authority
FI
Finland
Prior art keywords
imidazolfoereningar
framstaellning och
och anvaendning
anvaendning
framstaellning
Prior art date
Application number
FI922905A
Other languages
English (en)
Other versions
FI922905L (fi
Inventor
Oskar Axelsson
Mikkel Thaning
Peter Moldt
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Publication of FI922905A0 publication Critical patent/FI922905A0/fi
Publication of FI922905L publication Critical patent/FI922905L/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30Nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Lubricants (AREA)
  • Eye Examination Apparatus (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
FI922905A 1991-06-24 1992-06-22 Framstaellning och anvaendning av imidazolfoereningar FI922905L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72002191A 1991-06-24 1991-06-24

Publications (2)

Publication Number Publication Date
FI922905A0 true FI922905A0 (fi) 1992-06-22
FI922905L FI922905L (fi) 1992-12-25

Family

ID=24892332

Family Applications (1)

Application Number Title Priority Date Filing Date
FI922905A FI922905L (fi) 1991-06-24 1992-06-22 Framstaellning och anvaendning av imidazolfoereningar

Country Status (14)

Country Link
EP (1) EP0520200B1 (fi)
JP (1) JPH05186432A (fi)
AT (1) ATE163290T1 (fi)
AU (1) AU653816B2 (fi)
CA (1) CA2071793A1 (fi)
DE (1) DE69224448T2 (fi)
DK (1) DK0520200T3 (fi)
ES (1) ES2113898T3 (fi)
FI (1) FI922905L (fi)
GR (1) GR3026467T3 (fi)
IE (1) IE921650A1 (fi)
NO (1) NO302119B1 (fi)
NZ (1) NZ242951A (fi)
ZA (1) ZA924117B (fi)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK40192D0 (da) * 1992-03-26 1992-03-26 Neurosearch As Imidazolforbindelser, deres fremstilling og anvendelse
DK154092D0 (da) * 1992-12-23 1992-12-23 Neurosearch As Imidazolforbindelser, deres fremstilling og anvendelse
AU675484B2 (en) * 1993-03-24 1997-02-06 Neurosearch A/S Benzimidazole compounds, their use and preparation
US5554630A (en) * 1993-03-24 1996-09-10 Neurosearch A/S Benzimidazole compounds
US5496826A (en) * 1994-09-02 1996-03-05 Bristol-Myers Squibb Company Pharmaceutical methods of using heterocyclic derivatives of N-phenylamides
TR199701219T1 (xx) * 1995-04-21 1998-03-21 Neurosearch A/S Benzimidazol bile�ikleri, bu bile�ikleri i�eren ispen�iyar� bile�ikler.
EP0997147B1 (en) * 1997-07-08 2006-03-15 Ono Pharmaceutical Co., Ltd. Amino acid derivatives
CA2315910A1 (en) * 1997-12-22 1999-07-01 Ajinomoto Co., Inc. Novel dihydropyridine derivative
TWI245035B (en) 1998-06-26 2005-12-11 Ono Pharmaceutical Co Amino acid derivatives and a pharmaceutical composition comprising the derivatives
WO2000001676A1 (en) * 1998-07-02 2000-01-13 Neurosearch A/S Potassium channel blocking agents
US6194447B1 (en) 1998-07-02 2001-02-27 Neurosearch A/S Bis (benzimidazole) derivatives serving as potassium blocking agents
KR100633349B1 (ko) 1998-07-14 2006-10-16 오노 야꾸힝 고교 가부시키가이샤 아미노산 유도체 및 이들을 유효 성분으로서 함유하는 약제
US6316440B1 (en) 1998-07-30 2001-11-13 Warner-Lambert Company Reduced dipeptide analogues as calcium channel antagonists
WO2000078719A1 (fr) 1999-06-23 2000-12-28 Ajinomoto Co., Inc. Derive de la dihydropyridine
SK287527B6 (sk) * 2000-01-14 2011-01-04 Bayer Schering Pharma Aktiengesellschaft 1,2-Diarylbenzimidazoly a ich farmaceutické použitie
US7115645B2 (en) 2000-01-14 2006-10-03 Schering Aktiengesellschaft 1,2 diarylbenzimidazoles and their pharmaceutical use
US7329679B2 (en) 2000-01-27 2008-02-12 Schering Aktiengesellschaft 1,2 Diarylbenzimidazoles and their pharmaceutical use
DE10135050A1 (de) * 2001-07-09 2003-02-06 Schering Ag 1-Ary1-2-N-, S- oder O-substituierte Benzimidazolderivate, deren Verwendung zur Herstellung von Arzneimitteln sowie diese Derivate enthaltende pharmazeutische Präparate
KR100873400B1 (ko) * 2002-10-17 2008-12-11 한국과학기술연구원 N-타입 칼슘 채널의 활성을 억제함으로써 우울증을감소시키는 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4492708A (en) * 1982-09-27 1985-01-08 Eli Lilly And Company Antiviral benzimidazoles
JPH0772181B2 (ja) * 1989-06-26 1995-08-02 株式会社大塚製薬工場 ベンズイミダゾール誘導体
NZ239540A (en) * 1990-09-24 1993-11-25 Neurosearch As 1-phenyl benzimidazole derivatives and medicaments

Also Published As

Publication number Publication date
EP0520200A2 (en) 1992-12-30
ZA924117B (en) 1993-03-31
NZ242951A (en) 1994-12-22
NO922475L (no) 1992-12-28
FI922905L (fi) 1992-12-25
AU653816B2 (en) 1994-10-13
AU1726792A (en) 1993-01-07
CA2071793A1 (en) 1992-12-25
DE69224448T2 (de) 1998-06-10
ES2113898T3 (es) 1998-05-16
EP0520200B1 (en) 1998-02-18
DK0520200T3 (da) 1998-09-23
EP0520200A3 (en) 1993-05-12
DE69224448D1 (de) 1998-03-26
JPH05186432A (ja) 1993-07-27
GR3026467T3 (en) 1998-06-30
IE921650A1 (en) 1992-12-30
ATE163290T1 (de) 1998-03-15
NO302119B1 (no) 1998-01-26
NO922475D0 (no) 1992-06-23

Similar Documents

Publication Publication Date Title
FI922905A0 (fi) Framstaellning och anvaendning av imidazolfoereningar.
MY131298A (en) 5-heteroyl indole derivatives
ES2179040T3 (es) Utilizacion de 5-fluoro-2'-desoxi-3'-tiacitidina para el tratamiento de la hepatitis b.
FI862011A0 (fi) Terapeutiska nukleosider.
FI961809A0 (fi) Uudet (R)-5-karbamoyyli-8-fluori-3-N,N-disubstituoitu-amino 3,4-dihydro-2H-1-bentsopyraanit
BG98902A (bg) Имидазолови производни и тяхната употреба като инхибитори на цитокин
DE69230140D1 (de) Antivirale nucleosidkombination
DE69606028D1 (de) Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzung
FI935134A0 (fi) Substituerade 3-aminokinuklidiner
CS553490A3 (en) Transdermal therapeutic system
ATE211467T1 (de) 4-amino-derivate der mycophenolsäure mit immun suppressiver wirkung
BG101118A (en) Therapeutical compounds
MX9200361A (es) Nuevo uso del antagonista de adenosina.
ES2049690T3 (es) Derivados de taxano, su preparacion y su uso en oncologia.
NO304595B1 (no) Terapeutisk aktive derivater av 1-naftylpyrazol-3-karboksamider, farmas°ytiske preparater inneholdende dem, og mellomprodukter for fremstilling av dem
IT1264530B (it) Impiego dei polisaccaridi nelle neuropatie atrofico degenerative
MX9403088A (es) Composiciones farmaceuticas que contienen deriva- dos de indol y metodos de uso.
ES2068714T3 (es) Derivados de pirimidina para aumentar la actividad antitumoral.
YU31592A (sh) 6-HETEROCIKLIČNI-4-AMINO-1,2,2a,3,4,5- HEKSAHIDROBENZ (cd) INDOLI
ES2153842T3 (es) Derivados de 3-oxo-pirido(1,2-a-)bencimidazol-4-carboxilo y de 4-oxo-azepino(1,2-a)bencimidazol-5-carboxilo utiles en el tratamiento de enfermedades del sistema nervioso central.
TW282455B (fi)
SE8302580D0 (sv) Substituerade iminoderivat av dihydrobensopyran och dihydrobensotiopyran och forfarande for deras framstellning
ZA893310B (en) Novel strobilurine derivatives,their preparation and their use
DE69009765D1 (de) Kynurensäurederivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ES2190499T3 (es) Uso de antagonistas de bradiquinina para la preparacion de medicamentos para el tratamiento y la prevencion de la enfermedad de alzheimer.